Reports
Sale
Global Cough Syrup Market Size, Analysis, Research Report, Forecast: By Product Type: Expectorants, Cough Suppressants, Combination Medications, Others; By Population Type: Pediatric, Adults; By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Channel, Others; Regional Analysis; Supplier Landscape; 2024-2032
Global Cough Syrup Market Outlook
The global cough syrup market size attained a value of about USD 6,222.00 million in 2023, driven by increasing cases of respiratory disorders, rising geriatric population, increased investments in R&D and innovations like new flavours for newborns, are aiding the market growth. The market is further expected to grow at a CAGR of 3.8% during the forecast period of 2024-2032 to reach nearly USD 9,749.26 million by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The Asia Pacific and the Latin America Region to Propel the Market Growth of Cough Syrup
Due to easier availability of cough syrups at retail pharmacies, a rise in the geriatric population, and less stringent laws regarding the abuse of cough and cold medicines in the region, the Asia Pacific accounted for a significant market share in 2019, based on revenue, and is expected to maintain its significance during the forecast period as well.
However, because governments are investing in the development of healthcare infrastructure and as the number of instances of respiratory illnesses rises, LAMEA is predicted to have a substantial CAGR throughout the forecast period. Cough syrup industry growth is likely to be aided by the high market potential in unexplored emerging markets.
Cough Syrup: Market Segmentation
Cough syrups have been used since ancient times to provide temporary relief to people suffering from sneezing, coughing, and runny noses, which are typically caused by a cold, a high temperature, or allergies. Cough syrups are prescribed by doctors and can be used by both adults and children. Cough syrups contain anti-allergic and mucolytic medicines, which give speedier relief from cough-related difficulties. It often inhibits the heavy mucus layer, allowing the patient to breathe normally and comfortably.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Product Type
- Expectorants
- Cough Suppressants
- Combination Medications
- Others
Market Breakup by Population Type
- Paediatric
- Adults
Market Breakup by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Channel
- Public Channel
Market Breakup by Region
- North America
- United States of America
- Canada
- Europe
- United Kingdom
- Germany
- France
- Italy
- Others
- Asia Pacific
- China
- Japan
- India
- ASEAN
- Australia
- Others
- Latin America
- Brazil
- Argentina
- Mexico
- Others
- Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Nigeria
- South Africa
- Others
The Increasing Demand for Smokeless Tobacco to Aid the Market Growth of Cough Syrup
The global demand for cough syrup is steadily rising, owing to a growth in the number of people suffering from chronic and acute respiratory disorders, such as asthma. In addition, the demand for cough syrup in the worldwide market is driven by the proportion of the geriatric population who are mostly suffering from chest-related issues. The simple availability of products in clinics is another element contributing to cough syrup's growing market share in the worldwide market. During the forecast period, the expanding research and development in the cough syrup industry are expected to create numerous growth chances in the worldwide market. In addition, cough syrup innovation in terms of flavour for newborns gives potential in the worldwide cough syrup industry. The growing public awareness also lays the groundwork for future global commercial potential.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Key Players in the Global Cough Syrup Market
The report gives a detailed analysis of the following key players in the global cough syrup market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Acella Pharmaceuticals LLC
- Bayer AG
- GlaxoSmithKline PLC
- Johnson & Johnson
- Pfizer Inc.
- Prestige Consumer Healthcare Inc.
- Reckitt Benckiser Group PLC
- Sanofi
- Sun Pharmaceutical Industries Limited
- The Procter & Gamble Company
The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product Type |
|
| Breakup by Population Type |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Cough Syrup Market Overview
3.1 Global Cough Syrup Market Historical Value (2017-2023)
3.2 Global Cough Syrup Market Forecast Value (2024-2032)
4 Global Cough Syrup Market Landscape
4.1 Global Cough Syrup Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Cough Syrup Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Drug Type
4.2.3 Analysis by Population type
4.2.4 Analysis by Therapy Type
4.2.5 Analysis by Distribution Channel
5 Global Cough Syrup Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Cough Syrup Market Segmentation
6.1 Global Cough Syrup Market by Product Type
6.1.1 Market Overview
6.1.2 Expectorants
6.1.3 Cough Suppressants
6.1.4 Combination Medications
6.1.5 Others
6.2 Global Cough Syrup Market by Population Type
6.2.1 Market Overview
6.2.2 Pediatric
6.2.3 Adults
6.3 Global Cough Syrup Market by Distribution Channel
6.3.1 Market Overview
6.3.2 Hospital Pharmacy
6.3.3 Retail Pharmacy
6.3.4 Online Channel
6.3.5 Public Channel
6.4 Global Cough Syrup Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Cough Syrup Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Cough Syrup Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Cough Syrup Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Cough Syrup Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Cough Syrup Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication Year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 Acella Pharmaceuticals LLC
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Bayer AG
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 GlaxoSmithKline PLC
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Johnson & Johnson
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Pfizer Inc.
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Prestige Consumer Healthcare Inc.
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Reckitt Benckiser Group PLC
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Sanofi
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 Sun Pharmaceutical Industries Limited
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 The Procter & Gamble Company
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
18 Global Cough Syrup Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
In 2023, the global market for cough syrup attained a value of USD 6,222.00 million.
The market is anticipated to grow at a CAGR of 3.8% during the forecast period of 2024-2032 to reach a value of USD 9,749.26 million by 2032.
The major drivers of the industry, such as increasing cases of respiratory disorders, rising geriatric population, increased investments in R&D and innovations like new flavours for newborns, are aiding the market growth.
The key market trend guiding the growth of the industry includes growing government investment and healthcare infrastructure.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The significant product types in the market include expectorants, cough suppressants, and combination medications.
The different age groups in the market for cough syrup are paediatric and adult.
The leading distribution channels in the market are retail pharmacy, hospital pharmacy, and online pharmacy.
The major players in the industry are Sanofi, GlaxoSmithKline plc, Mankind Pharma Ltd., Novartis AG, and Reckitt Benckiser Group Plc, among others.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 3499
$1999
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5999
$2999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 7999
$3999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 9999
$5999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER